Ignyte Acquisition Corp
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with cancer, inflammatory, and rare diseases in the United States. The company's lead product candidate is PHP-303, which is in Phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an… Read more
Market Cap & Net Worth: Ignyte Acquisition Corp (PKBO)
Ignyte Acquisition Corp (PINK:PKBO) has a market capitalization of $520.31K ($520.31K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #39181 globally and #12765 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ignyte Acquisition Corp's stock price $0.02 by its total outstanding shares 23124900 (23.12 Million).
Ignyte Acquisition Corp Market Cap History: 2022 to 2024
Ignyte Acquisition Corp's market capitalization history from 2022 to 2024. Data shows change from $96.89 Million to $520.31K (-95.27% CAGR).
Ignyte Acquisition Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ignyte Acquisition Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
159.45x
Ignyte Acquisition Corp's market cap is 159.45 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $96.89 Million | $607.68K | -$13.09 Million | 159.45x | N/A |
Competitor Companies of PKBO by Market Capitalization
Companies near Ignyte Acquisition Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Ignyte Acquisition Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Ignyte Acquisition Corp Historical Marketcap From 2022 to 2024
Between 2022 and today, Ignyte Acquisition Corp's market cap moved from $96.89 Million to $ 520.31K, with a yearly change of -95.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $520.31K | -88.03% |
| 2023 | $4.35 Million | -95.51% |
| 2022 | $96.89 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 13th, 2025 the market cap of Ignyte Acquisition Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $520.31K USD |
| MoneyControl | $520.31K USD |
| MarketWatch | $520.31K USD |
| marketcap.company | $520.31K USD |
| Reuters | $520.31K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.